Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.

Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK.

Mol Cancer. 2019 Apr 2;18(1):75. doi: 10.1186/s12943-019-0991-5. Review.

2.

Exosomes from Nischarin-Expressing Cells Reduce Breast Cancer Cell Motility and Tumor Growth.

Maziveyi M, Dong S, Baranwal S, Mehrnezhad A, Rathinam R, Huckaba TM, Mercante DE, Park K, Alahari SK.

Cancer Res. 2019 May 1;79(9):2152-2166. doi: 10.1158/0008-5472.CAN-18-0842. Epub 2019 Jan 11.

PMID:
30635277
3.

Development of insulin resistance in Nischarin mutant female mice.

Dong S, Blüher M, Zhang Y, Wu H, Alahari SK.

Int J Obes (Lond). 2019 May;43(5):1046-1057. doi: 10.1038/s41366-018-0241-8. Epub 2018 Dec 13.

PMID:
30546133
4.

Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.

Eastlack SC, Dong S, Ivan C, Alahari SK.

Mol Cancer. 2018 Jul 16;17(1):100. doi: 10.1186/s12943-018-0851-8.

5.

Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer.

Eastlack SC, Dong S, Mo YY, Alahari SK.

PLoS One. 2018 Jun 18;13(6):e0198945. doi: 10.1371/journal.pone.0198945. eCollection 2018.

6.

Nischarin regulates focal adhesion and Invadopodia formation in breast cancer cells.

Maziveyi M, Dong S, Baranwal S, Alahari SK.

Mol Cancer. 2018 Feb 7;17(1):21. doi: 10.1186/s12943-018-0764-6.

7.

Measurement of cell traction force with a thin film PDMS cantilever.

Holley MT, YekrangSafakar A, Maziveyi M, Alahari SK, Park K.

Biomed Microdevices. 2017 Nov 4;19(4):97. doi: 10.1007/s10544-017-0239-3.

PMID:
29103075
8.

Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase.

Dong S, Baranwal S, Garcia A, Serrano-Gomez SJ, Eastlack S, Iwakuma T, Mercante D, Mauvais-Jarvis F, Alahari SK.

J Biol Chem. 2017 Oct 13;292(41):16833-16846. doi: 10.1074/jbc.M117.784256. Epub 2017 Aug 24.

9.

Cell matrix adhesions in cancer: The proteins that form the glue.

Maziveyi M, Alahari SK.

Oncotarget. 2017 Jul 18;8(29):48471-48487. doi: 10.18632/oncotarget.17265. Review.

10.

The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.

O'Bryan S, Dong S, Mathis JM, Alahari SK.

Eur J Cancer. 2017 Feb;72:1-11. doi: 10.1016/j.ejca.2016.11.004. Epub 2016 Dec 18. Review.

PMID:
27997852
11.

Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate Cancer.

Alahari SV, Eastlack SC, Alahari SK.

Int Rev Cell Mol Biol. 2016;324:229-54. doi: 10.1016/bs.ircmb.2016.01.004. Epub 2016 Mar 2. Review.

PMID:
27017010
12.

Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.

Serrano-Gomez SJ, Maziveyi M, Alahari SK.

Mol Cancer. 2016 Feb 24;15:18. doi: 10.1186/s12943-016-0502-x. Review.

13.

Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin.

Maziveyi M, Alahari SK.

Cancer Res. 2015 Oct 15;75(20):4252-9. doi: 10.1158/0008-5472.CAN-15-1395. Epub 2015 Sep 21. Review.

14.

Primary Tumor and MEF Cell Isolation to Study Lung Metastasis.

Dong S, Maziveyi M, Alahari SK.

J Vis Exp. 2015 May 20;(99):e52609. doi: 10.3791/52609.

15.

MicroRNA and Breast Cancer: Understanding Pathogenesis, Improving Management.

Eastlack SC, Alahari SK.

Noncoding RNA. 2015 Apr 20;1(1):17-43. doi: 10.3390/ncrna1010017. Review.

16.

Are macrophages in tumors good targets for novel therapeutic approaches?

Alahari SV, Dong S, Alahari SK.

Mol Cells. 2015;38(2):95-104. doi: 10.14348/molcells.2015.2298. Epub 2014 Dec 16. Review.

17.

Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration of breast epithelial cells.

Jain P, Baranwal S, Dong S, Struckhoff AP, Worthylake RA, Alahari SK.

J Biol Chem. 2013 May 31;288(22):15495-509. doi: 10.1074/jbc.M112.418103. Epub 2013 Apr 9.

18.

Rac and Rab GTPases dual effector Nischarin regulates vesicle maturation to facilitate survival of intracellular bacteria.

Kuijl C, Pilli M, Alahari SK, Janssen H, Khoo PS, Ervin KE, Calero M, Jonnalagadda S, Scheller RH, Neefjes J, Junutula JR.

EMBO J. 2013 Mar 6;32(5):713-27. doi: 10.1038/emboj.2013.10. Epub 2013 Feb 5.

19.

Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer.

Jin L, Wessely O, Marcusson EG, Ivan C, Calin GA, Alahari SK.

Cancer Res. 2013 May 1;73(9):2884-96. doi: 10.1158/0008-5472.CAN-12-2162. Epub 2013 Jan 21.

20.

Quantitative analysis of random migration of cells using time-lapse video microscopy.

Jain P, Worthylake RA, Alahari SK.

J Vis Exp. 2012 May 13;(63):e3585. doi: 10.3791/3585.

21.

Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.

Baranwal S, Wang Y, Rathinam R, Lee J, Jin L, McGoey R, Pylayeva Y, Giancotti F, Blobe GC, Alahari SK.

J Natl Cancer Inst. 2011 Oct 19;103(20):1513-28. doi: 10.1093/jnci/djr350. Epub 2011 Sep 14.

22.

Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis.

Wang Y, Shenouda S, Baranwal S, Rathinam R, Jain P, Bao L, Hazari S, Dash S, Alahari SK.

Mol Cancer. 2011 Jul 13;10:84. doi: 10.1186/1476-4598-10-84.

23.

Role of Rho GTPases and their regulators in cancer progression.

Rathinam R, Berrier A, Alahari SK.

Front Biosci (Landmark Ed). 2011 Jun 1;16:2561-71. Review.

PMID:
21622195
24.

Rho GTPase effector functions in tumor cell invasion and metastasis.

Baranwal S, Alahari SK.

Curr Drug Targets. 2011 Jul 1;12(8):1194-201. Review.

PMID:
21561416
25.

Breast cancer stem cells: a new challenge for breast cancer treatment.

Jain P, Alahari SK.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1824-32. Review.

PMID:
21196267
26.

Integrin-mediated function of Rab GTPases in cancer progression.

Subramani D, Alahari SK.

Mol Cancer. 2010 Dec 9;9:312. doi: 10.1186/1476-4598-9-312. Review.

27.

Important role of integrins in the cancer biology.

Rathinam R, Alahari SK.

Cancer Metastasis Rev. 2010 Mar;29(1):223-37. doi: 10.1007/s10555-010-9211-x. Review.

PMID:
20112053
28.

Stromal cells and integrins: conforming to the needs of the tumor microenvironment.

Alphonso A, Alahari SK.

Neoplasia. 2009 Dec;11(12):1264-71. Review.

29.

MicroRNA function in cancer: oncogene or a tumor suppressor?

Shenouda SK, Alahari SK.

Cancer Metastasis Rev. 2009 Dec;28(3-4):369-78. doi: 10.1007/s10555-009-9188-5. Review.

PMID:
20012925
30.

miRNA control of tumor cell invasion and metastasis.

Baranwal S, Alahari SK.

Int J Cancer. 2010 Mar 15;126(6):1283-90. doi: 10.1002/ijc.25014. Review.

31.

ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation.

Wang Y, Rathinam R, Walch A, Alahari SK.

J Biol Chem. 2009 Aug 21;284(34):23094-106. doi: 10.1074/jbc.M109.012617. Epub 2009 Jun 22.

32.

Molecular mechanisms controlling E-cadherin expression in breast cancer.

Baranwal S, Alahari SK.

Biochem Biophys Res Commun. 2009 Jun 19;384(1):6-11. doi: 10.1016/j.bbrc.2009.04.051. Epub 2009 Apr 18. Review.

33.

Nischarin inhibits LIM kinase to regulate cofilin phosphorylation and cell invasion.

Ding Y, Milosavljevic T, Alahari SK.

Mol Cell Biol. 2008 Jun;28(11):3742-56. doi: 10.1128/MCB.01832-07. Epub 2008 Mar 10.

34.

The integrin-binding protein Nischarin regulates cell migration by inhibiting PAK.

Alahari SK, Reddig PJ, Juliano RL.

EMBO J. 2004 Jul 21;23(14):2777-88. Epub 2004 Jul 1.

35.
37.

Biological aspects of signal transduction by cell adhesion receptors.

Alahari SK, Reddig PJ, Juliano RL.

Int Rev Cytol. 2002;220:145-84. Review.

PMID:
12224548
38.
39.

Calcium-dependent properties of CIB binding to the integrin alphaIIb cytoplasmic domain and translocation to the platelet cytoskeleton.

Shock DD, Naik UP, Brittain JE, Alahari SK, Sondek J, Parise LV.

Biochem J. 1999 Sep 15;342 Pt 3:729-35.

40.

Novel cationic amphiphiles as delivery agents for antisense oligonucleotides.

DeLong RK, Yoo H, Alahari SK, Fisher M, Short SM, Kang SH, Kole R, Janout V, Regan SL, Juliano RL.

Nucleic Acids Res. 1999 Aug 15;27(16):3334-41.

41.

Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression.

Alahari SK, DeLong R, Fisher MH, Dean NM, Viliet P, Juliano RL.

J Pharmacol Exp Ther. 1998 Jul;286(1):419-28.

PMID:
9655887
42.

Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins.

Aplin AE, Howe A, Alahari SK, Juliano RL.

Pharmacol Rev. 1998 Jun;50(2):197-263. Review. No abstract available.

PMID:
9647866
43.

Integrin signaling and cell growth control.

Howe A, Aplin AE, Alahari SK, Juliano RL.

Curr Opin Cell Biol. 1998 Apr;10(2):220-31. Review.

PMID:
9561846
44.

Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.

Alahari SK, Dean NM, Fisher MH, Delong R, Manoharan M, Tivel KL, Juliano RL.

Mol Pharmacol. 1996 Oct;50(4):808-19.

PMID:
8863825
45.

Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy.

Zerva L, Cizman B, Mehra NK, Alahari SK, Murali R, Zmijewski CM, Kamoun M, Monos DS.

J Exp Med. 1996 Mar 1;183(3):829-36.

46.
47.
48.

Detection of CD2 polymorphism on chromosome 1 with EcoRI.

Malter JS, Moolten DN, Alahari SK, Makni H, Kant JA, Kamoun M.

Nucleic Acids Res. 1990 Nov 11;18(21):6465. No abstract available.

Supplemental Content

Loading ...
Support Center